In the realm of anti-infective therapy, antimicrobials constitute a diverse arsenal against various pathogens. Antibacterial drugs, commonly known as antibiotics, are fundamental in treating bacterial infections. Their mechanisms range from inhibiting bacterial cell wall synthesis to disrupting protein synthesis, showcasing their versatility. Antiviral medications are crucial in managing viral infections, with some targeting specific stages of the viral life cycle. Antifungal therapy addresses fungal infections, ranging from superficial skin conditions to life-threatening systemic mycoses. Combination therapies, incorporating multiple antimicrobial agents, are sometimes employed to enhance efficacy and combat resistance. Striking a balance between effective treatment and preventing resistance is paramount for the continued success of anti-infective therapy in managing infectious diseases.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : A rare case of meningitis and septicemia due to Streptococcus acidominimus
Percival C Dilla, Region II Trauma and Medical Center, Philippines
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Association between cardiometabolic risk factors and COVID-19 severity in patients of a rural tertiary hospital
Percival C Dilla, Region II Trauma and Medical Center, Philippines